Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2026 08:30 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval

PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
February 11, 2026 18:51 ET | Source: Precision Drilling Corporation

Precision Drilling Announces 2025 Fourth Quarter and Year End Unaudited Financial Results

CALGARY, Alberta, Feb. 11, 2026 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of...
February 03, 2026 07:51 ET | Source: Research and Markets

Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant...
January 28, 2026 08:45 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI

NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate Cancer PRINCETON, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology...
January 27, 2026 21:39 ET | Source: Moomoo

Moomoo partners with Nasdaq in new era in options trading

Moomoo's 28 million investors worldwide gained immediate access to Nasdaq's newly launched Monday and Wednesday weekly options this week, as the investment
January 22, 2026 08:45 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101

PRINCETON, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
January 09, 2026 08:45 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE...
January 06, 2026 08:00 ET | Source: Precision Drilling Corporation

Precision Drilling Meets Annual Capital Allocation Targets and Provides Financial and Operational Updates

CALGARY, Alberta, Jan. 06, 2026 (GLOBE NEWSWIRE) -- This news release contains "forward-looking information and statements" within the meaning of applicable securities laws. For a full disclosure of...
January 05, 2026 16:30 ET | Source: Precision Drilling Corporation

Precision Drilling Corporation 2025 Fourth Quarter and Year-End Results Conference Call and Webcast

CALGARY, Alberta, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) intends to release its 2025 fourth quarter and year-end results after the market closes on Wednesday,...
December 29, 2025 09:00 ET | Source: The American Kennel Club

Lhasa Apso “JJ” Wins Best in Show at 25th AKC® National Championship Presented by Royal Canin

ORLANDO, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- GCHP CH Ta Sen Westgate Jingle Juice, a Lhasa Apso known as “JJ” triumphed over more than 5,500 competitors to earn a $50,000 cash prize when they...